Roswell Park Welcomes New Chief of Lymphoma Clinical Section: Dorothy Pan, MD

Name: Roswell Park Welcomes New Chief of Lymphoma Clinical Section: Dorothy Pan, MD
Uploaded: 2023-03-01T00:00:00+00:00
Description: Dorothy Pan, MD, is joining Roswell Park Comprehensive Cancer Center as the Chief of the Lymphoma Clinical Section in the Department of Medicine.

Dorothy Pan, MD, is a highly skilled Hematologic Oncologist with experience treating various hematologic malignancies, including Chronic Lymphocytic Leukemia and Lymphoma. She is joining Roswell Park Comprehensive Cancer Center as the Chief of the Lymphoma Clinical Section in the Department of Medicine. In this video, Dr. Pan discusses her work, what brought her to Roswell Park, and what excites her about the future of treating hematologic malignancies.

Created by

Related Presenters

Dorothy Pan, MD

Chief, Lymphoma Clinical Service
Associate Professor of Hematology/Oncology

Background Education and Training: 1995 - MD - Weill Cornell Medical College, New York, NY 1991 - BS - Biology, Massachusetts Institute of Technology, Cambridge MA Residency: 1995-1998 - Internal Medicine, Montefiore Medical ...

View full profile

Related Videos

Video

Meet the Team: Dr. Ehsan Malek

As the Director of the Multiple Myeloma Translational Research Program at Roswell Park, Dr. Malek brings with him a passion for finding new and innovative treatments for this disease and other plasma cell disorders

Video

Updates and Advancements in Cellular Therapy at Roswell Park

Originally Broadcast: Thursday, November 9, 2023 6:00 - 7:30 PM EST - This program is intended for Hematologists, Oncologists, Pharmacists, Pathologists, and other healthcare professionals that care for cancer patients.

Video

Roswell Park Welcomes New Vice Chair of Clinical Affairs: Dr. Peter Maslak

Peter Maslak, MD, is an expert Hematologic Oncologist, joining Roswell Park as Vice Chair of Clinical Affairs, Director of Flow Cytometry in the Immune Monitoring Shared Resource and the Technical Director of the Flow Cytometry Lab.

Video

CAR T-Cell Therapy Proves Effective in First Trial in Patients with Resistant Multiple Myeloma

A therapy made of immune system T cells engineered to target a somewhat enigmatic cell protein called GPRC5D antigen produced impressive results in its first clinical trial in patients with multiple myeloma, researchers at Memorial Sloan ...

Video

Warning Signs of Hematologic Malignancies in the Primary Care Setting

Eunice Wang, MD, Chief of the Leukemia Service at Roswell Park Comprehensive Cancer Center, offers guidance on what red flags may indicate a hematologic cancer in your patients to help you identify these complex and often difficult-to-treat ...

Video

Benefits of Combining Beta-Blocker and Checkpoint Inhibitor

The same biochemical triggers that spur a “fight or flight” response when we encounter threats may help tumor cells to thrive.

Video

Mapping the Battlefield: Imaging of Multiple Myeloma

Jens Hillengass, MD, shares a history of myeloma imaging, the variety of sophisticated imaging techniques available, and shares several examples to help determine diagnosis.